Celebrating Audit Participation: Introducing NEIAA Certificates of Achievement
We're delighted to announce that an editable certificate is now available for clinical leads to award to colleagues for their contributions to the National Early Inflammatory Arthritis Audit (NEIAA). The certificate can be downloaded by Clinical Leads (under the User Admin tab) and the accompanying certificate guidance can also be found on the Resources page. Clinical Leads are welcome to directly award these to colleagues who have recruited at least five eligible patients to the audit. This includes rheumatology trainees, healthcare professionals and admin staff.
BSR E-Learning Spotlight on NEIAA
The British Society for Rheumatology has carefully curated a range of educational resources exploring the National Early Inflammatory Arthritis Audit in its e-learning spotlight for February 2024. Create a free BSR account today, and access the e-learning here:
https://www.rheumatologylearning.com/
New Resource: Standard Responses to Referrals and Requests for Specialist Advice
BSR has developed standard responses to referrals and requests for specialist advice with input from clinicians and specialist across the UK. We hope these documents will help your department to more efficiently respond to common advice requests from referrers. You can find out more on our website, where you will also find our Referral Criteria Guidance and Best Practice resources:
https://www.rheumatology.org.uk/improving-care/specialist-advice-referral-and-triage.
National Data Opt-out (NDO) Update
The National Early Inflammatory Arthritis Audit (NEIAA) is no longer exempt from the National Data Opt-out (NDO), as of 7 July 2023. Clinical teams must now check each patient's NDO status before submitting any confidential patient data into the audit. Further information can be found here.
Resources have been compiled by NHS Digital to support with NDO compliance, these can be found here.
Patient Eligibility From 1 April 23
Patient eligibility within the audit has changed from 1 April 23. Patients should now only be entered into the audit when they have a confirmed diagnosis of EIA (Rheumatoid arthritis, Psoriatic arthritis, Axial spondyloarthropathy, Undifferentiated inflammatory arthritis). Year 4 data suggests this will result in a 65% reduction in data burden. In addition to this, patients with confirmed diagnosis of CTD and Systemic Vasculitis, a full list of diagnosis are listed here
CTD:
Systemic lupus erythematosus
Primary Sjogren’s syndrome
Systemic sclerosis
Idiopathic inflammatory myopathy
Undifferentiated/other connect tissue disease or overlap syndrome
Systemic Vasculitis:
Giant cell arthritis
Large vessel vasculitis (not giant cell arteritis)
Anti-neutrophil cytoplasmic antibody-associated vasculitis
Small/medium vessel vasculitis (anti-neutrophil cytoplasmic antibody-negative)
Behcet’s syndrome
There is more information about the changes to data collection here: Changes to The National Early Inflammatory Arthritis Audit (rheumatology.org.uk).
If you have any questions about these changes, please contact the team at audit@rheumatology.org.uk.
Submitting Audit Data
Data collection is open for Year 6 (1 April 2023 - 31 March 2024). Patients recruited during this period should be entered into the audit by 31 March 2024. Please contact the audit team with any queries at audit@rheumatology.org.uk.
Log in to submit your data
Winner of the 2020 Richard Driscoll Memorial Award for outstanding work in patient and public involvement
